Blog
Pearl Pathways honored in 2014 Indiana Companies to Watch
Pearl Pathways is pleased to announce our recognition as one of the 2014 Indiana Companies to Watch, presented by the Indiana Office of Small Business and Entrepreneurship (OSBE), its Indiana Small Business Development Center, the Indiana Economic Development...
FDA issues new draft guidance on informed consent
After sixteen years FDA has released a new draft guidance with updated regulations concerning the obtainment of informed consent from clinical trial subjects. The guidance begins by reiterating the basic process for obtaining consent, beyond written documentation. FDA...
Pearl Pathways hires Zac Unger
We are pleased to announce the hiring of Zac Unger as a Regulatory Analyst. Unger brings a strong blend of Information Technology (IT), document publishing, and software systems to the Pearl Pathways team. To read the full press release, click here.
EU hopes to increase clinical trial applications with new legislation
The European Union (EU) recently published over 70 pages of legislation to conclude the long, exhaustive effort to remedy their old system of clinical trial regulations. Daniel Cressey’s article on nature.com highlights important takeaways from the legislation as well...
Heidi Strunk presenting at IMDMC Regulatory 101 on August 19th
We invite you to join us at the second session of Indiana Medical Device Manufacturers Council (IMDMC)’s annual Regulatory 101 course on August 19, 2014. This is a popular event designed for staff who are new to the FDA regulatory world or those who just need a...